Key Players
Competitive Landscape
Four supplier models compete in the cell migration and cell invasion assay market: diversified life-science groups, assay and extracellular-matrix specialists, automated imaging manufacturers and regional laboratory distributors.
From 2025 onward investment has concentrated on defined extracellular matrices and faster automated imaging. Bio-Techne launched Cultrex Synthetic Hydrogel in February 2026 to reduce lot variability in scalable three-dimensional workflows. Molecular Devices launched ImageXpress HCS.ai in January 2025 with three-dimensional volumetric analysis of a 384-well plate in 25 minutes. Laboratories compare biological reproducibility, acquisition speed and software traceability during purchasing decisions for complex migration or invasion workflows.
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| In February 2026 Bio-Techne launched Cultrex Synthetic Hydrogel as a defined ECM alternative for scalable three-dimensional culture. | Laboratories need controlled matrices that reduce lot variation across repeated invasion studies and method transfers. | Three-dimensional models are shifting from variable biological matrices toward defined synthetic materials with documented composition. | Validated hydrogel kits and application support can serve repeatable spheroid or organoid invasion workflows. |
| In January 2025 Molecular Devices launched ImageXpress HCS.ai with 384-well three-dimensional analysis completed in 25 minutes. | Imaging laboratories need faster acquisition and analysis for complex cell models across larger screening programs. | High-content platforms increasingly combine automated image capture with software-assisted analysis inside one instrument workflow. | Instrument upgrades, software licenses and service contracts can support higher-throughput migration or invasion screening. |
| In April 2025 Thermo Fisher Scientific reported a technology alliance with the Chan Zuckerberg Institute for Advanced Biological Imaging. | Researchers need clearer visualization of human-cell behavior across detailed biological models and dynamic experimental conditions. | Imaging companies are linking technology development with research institutes to improve biological resolution and workflow relevance. | Advanced imaging programs can support live-cell studies that require higher spatial detail and specialist application support. |
Corning presented three-dimensional cell-culture and high-content screening tools at SLAS 2025. Merck reports a broad Science and Lab Solutions business, although neither official source documents an exact-market launch from January 2025 to August 2026.
Source: Future Market Insights, Cell Migration and Cell Invasion Assay Market and High-Content Screening Market Reports, 2026-2036.
Bio-Techne and Molecular Devices cover defined extracellular matrices plus high-content acquisition with three-dimensional analysis. Corning adds three-dimensional culture tools and optical microplates for imaging workflows.
Who leads the cell migration and cell invasion assay market?
Leadership varies by workflow stage across assay inputs and automated imaging systems. Corning and Thermo Fisher cover broad laboratory inputs. Sartorius, Agilent and Molecular Devices compete with live-cell or high-content analysis platforms.
Which suppliers have documented qualification or quality controls?
Agilent documents secure authentication, electronic signatures and audit trails for xCELLigence RTCA eSight. Bio-Techne describes a fully defined synthetic matrix that reduces lot variation across scalable three-dimensional workflows.
Which companies provide three-dimensional invasion products?
Bio-Techne supplies a defined synthetic extracellular matrix for three-dimensional culture. Corning supports 3D cell-culture workflows. Sartorius and Molecular Devices provide imaging systems for continuous or high-content analysis of complex cell models.
Which suppliers serve North America and Europe?
Thermo Fisher, Corning, Merck KGaA and Bio-Techne maintain international life-science operations across North America and Europe. Agilent, Revvity, Danaher and Sartorius provide instrument or software coverage with established commercial networks in both regions.
Representative Company Overview
| Company | Positioning | Verified market-relevant capabilities |
|---|---|---|
| Thermo Fisher Scientific Inc. | Global | Cell-analysis instruments and advanced biological imaging research supported by a 2025 institutional technology alliance. |
| Corning Incorporated | Global | Three-dimensional cell-culture tools, optical microplates and automation consumables for drug-discovery workflows. |
| Merck KGaA | Global | Broad research tools and laboratory supply within Science and Lab Solutions with no exact-market launch documented during the reviewed period. |
| Agilent Technologies, Inc. | Global | xCELLigence real-time cell analysis with potency-assay use plus controlled-access and audit-trail software. |
| Bio-Techne Corporation | Global | Cultrex extracellular-matrix products plus a defined synthetic hydrogel for scalable three-dimensional models. |
| Revvity, Inc. | Global | Phenologic.AI and Harmony software for brightfield or high-content cellular imaging. |
| Danaher Corporation | Global | Molecular Devices ImageXpress HCS.ai imaging with software-assisted three-dimensional analysis. |
| Sartorius AG | Global | Incucyte live-cell analysis with confocal imaging and parallel measurement of complex three-dimensional models. |
Research Methodology
The selected companies illustrate market structure across assay inputs and automated analysis. The table does not rank them. Company inclusion requires current evidence for cell-based assay inputs, extracellular-matrix materials, live-cell imaging or related analysis capabilities. Evidence comes from official company releases, filings and event pages reviewed for current relevance.
